Myomo (MYO) Net Margin (2016 - 2025)
Myomo posted quarterly Net Margin of 36.3% for Q3 2025, down 2580.0% year-on-year from 1.46% in Q3 2024, and up 24.36% on a QoQ basis from 47.99% in Q2 2025.
Myomo (MYO) has 10 years of Net Margin data on file, last reported at 36.3% in Q3 2025.
- For the quarter ending Q3 2025, Net Margin fell 2580.0% year-over-year to 36.3%; the trailing twelve-month figure through Sep 2025 stood at 12.48% (down 1380.0% YoY), and the FY2024 full-year result was 1.97%, down 99.0% from the prior year.
- Net Margin for Q3 2025 stood at 36.3%, up from 47.99% in the prior quarter.
- Across five years, Net Margin topped out at 131.54% in Q4 2023 and bottomed at 126.72% in Q1 2021.
- The 5-year median for Net Margin is 47.99% (2025), against an average of 43.05%.
- The widest annual swing landed in 2021, when Net Margin soared 31693 bps; it then sank 7715 bps in 2024.
- A 5-year view of Net Margin shows it stood at 83.67% in 2021, then soared by 31 bps to 58.1% in 2022, then jumped by 326 bps to 131.54% in 2023, then sank by 59 bps to 54.4% in 2024, then slumped by 167 bps to 36.3% in 2025.
- The last three Net Margin figures came in at 36.3% (Q3 2025), 47.99% (Q2 2025), and 35.24% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -36.30% |
| Jun 30, 2025 | -47.99% |
| Mar 31, 2025 | -35.24% |
| Dec 31, 2024 | 54.40% |
| Sep 30, 2024 | -10.50% |
| Jun 30, 2024 | -14.91% |
| Mar 31, 2024 | -102.16% |
| Dec 31, 2023 | 131.54% |
| Sep 30, 2023 | -39.95% |
| Jun 30, 2023 | -17.02% |
| Mar 31, 2023 | -76.72% |
| Dec 31, 2022 | -58.10% |
| Sep 30, 2022 | -71.31% |
| Jun 30, 2022 | -79.10% |
| Mar 31, 2022 | -72.78% |
| Dec 31, 2021 | -83.67% |
| Sep 30, 2021 | -46.92% |
| Jun 30, 2021 | -84.44% |
| Mar 31, 2021 | -126.72% |
| Dec 31, 2020 | -44.81% |
| Sep 30, 2020 | -144.11% |
| Jun 30, 2020 | -382.83% |
| Mar 31, 2020 | -443.65% |
| Dec 31, 2019 | -181.59% |
| Sep 30, 2019 | -459.62% |
| Jun 30, 2019 | -291.40% |
| Mar 31, 2019 | -409.09% |
| Dec 31, 2018 | -302.61% |
| Sep 30, 2018 | -435.12% |
| Jun 30, 2018 | -415.83% |
| Mar 31, 2018 | -748.90% |
| Dec 31, 2017 | -2,447.55% |
| Sep 30, 2017 | -257.70% |
| Jun 30, 2017 | -2,528.53% |
| Mar 31, 2017 | -9,434.91% |
| Dec 31, 2016 | -313.32% |
| Sep 30, 2016 | -657.42% |
| Jun 30, 2016 | -374.21% |